Lim SM, Fujino T, Kim C, Lee G, et al. BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer. Clin Cancer Res 2023 May 30:CCR-22-3901. doi: 10.1158/1078-0432.CCR-22-3901.
PMID: 37249619